Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01358760 · ClinicalTrials.gov registry record · Phase 3
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
A Phase 3 study, sponsored by EndoCeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 450
- Enrollment target
NCT01358760 is a Phase 3 study that has completed, run by EndoCeutics. The registered enrollment target is 450 participants.
The verdict
NCT01358760, a Phase 3 study, has completed, sponsored by EndoCeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 450 participants
- Enrollment target
Study Summary
The purpose of this Phase III trial is to evaluate the efficacy of intravaginal dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.
Interventions
- DRUG Placebo
- DRUG DHEA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01358760
The ClinicalTrials.gov registry entry for NCT01358760 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EndoCeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01358760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01358760 about?
NCT01358760 is a clinical study titled "Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy". The purpose of this Phase III trial is to evaluate the efficacy of intravaginal dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.
What is the current status of trial NCT01358760?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 450 participants. The study started on 2011-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01358760?
The interventions under investigation include: Placebo (DRUG), DHEA (DRUG).
Who is sponsoring clinical trial NCT01358760?
This trial is sponsored by EndoCeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.